| Product NDC: | 63323-407 |
| Proprietary Name: | Caffeine Citrate |
| Non Proprietary Name: | CAFFEINE CITRATE |
| Active Ingredient(s): | 20 mg/mL & nbsp; CAFFEINE CITRATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-407 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077997 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091119 |
| Package NDC: | 63323-407-03 |
| Package Description: | 1 VIAL in 1 BOX (63323-407-03) > 3 mL in 1 VIAL |
| NDC Code | 63323-407-03 |
| Proprietary Name | Caffeine Citrate |
| Package Description | 1 VIAL in 1 BOX (63323-407-03) > 3 mL in 1 VIAL |
| Product NDC | 63323-407 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CAFFEINE CITRATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091119 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | CAFFEINE CITRATE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |